Difference between revisions of "Team:Exeter/Collaborations"

Line 736: Line 736:
  
 
                 <p id="pp">Graph of these averages. The error bars are standard deviation but are very small because the 3 replicates for each sample are technical replicates, so do not show the variation that would be seen with biological replicates (3 different colonies for each of the 16 samples).</p>
 
                 <p id="pp">Graph of these averages. The error bars are standard deviation but are very small because the 3 replicates for each sample are technical replicates, so do not show the variation that would be seen with biological replicates (3 different colonies for each of the 16 samples).</p>
 +
 +
<br>
 +
<br>
  
 
                 <div class="col-xs-12" style="padding:0;margin:0;">
 
                 <div class="col-xs-12" style="padding:0;margin:0;">
Line 744: Line 747:
  
 
                 <p id="pp">Fluorescence scan image from the Typhoon with labels for which samples are in each well.</p>
 
                 <p id="pp">Fluorescence scan image from the Typhoon with labels for which samples are in each well.</p>
 +
<br>
 +
<br>
  
 
                 <div class="col-xs-12" style="padding:0;margin:0;">
 
                 <div class="col-xs-12" style="padding:0;margin:0;">
Line 756: Line 761:
  
 
                 <p id="pp">Another reason there may not be any KillerRed or KillerOrange protein produced, is mutations in the promoter. This was something we encountered when attempting to clone a promoter in front of the toxin from the toxin-antitoxin system we were working with. If a protein is toxic to produce, any cell which is producing less or no protein will grow faster than a cell which is producing the toxic protein. This means a mutated, non-functional promoter will have a proliferative advantage during transformation. So, as we were sending our BioBricks for registry for submission, we decided to sequence the minipreps of KillerRed and KillerOrange as well with the registry standard pSB1C3 sequencing primer VF2, to check for any mutations. The results are shown below in screenshots of a plasmid editor software called ApE.</p>
 
                 <p id="pp">Another reason there may not be any KillerRed or KillerOrange protein produced, is mutations in the promoter. This was something we encountered when attempting to clone a promoter in front of the toxin from the toxin-antitoxin system we were working with. If a protein is toxic to produce, any cell which is producing less or no protein will grow faster than a cell which is producing the toxic protein. This means a mutated, non-functional promoter will have a proliferative advantage during transformation. So, as we were sending our BioBricks for registry for submission, we decided to sequence the minipreps of KillerRed and KillerOrange as well with the registry standard pSB1C3 sequencing primer VF2, to check for any mutations. The results are shown below in screenshots of a plasmid editor software called ApE.</p>
 +
 +
<br>
 +
<br>
  
 
<div class="col-xs-12" style="padding:0;margin:0;">
 
<div class="col-xs-12" style="padding:0;margin:0;">

Revision as of 18:25, 11 October 2016